BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8152558)

  • 1. [Lymphocytic infiltration in thyroid neoplasms. Preliminary prognostic assessments].
    Mancini A; Rabitti C; Conte G; Gullotta G; De Marinis L
    Minerva Chir; 1993 Nov; 48(21-22):1283-8. PubMed ID: 8152558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hashimoto's thyroiditis and carcinoma of the thyroid gland.
    Segal K; Ben-Bassat M; Avraham A; Har-El G; Sidi J
    Int Surg; 1985; 70(3):205-9. PubMed ID: 3841752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship between the pathological characteristics and the prognosis of thyroid carcinoma].
    Liu FS
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):381-4. PubMed ID: 8174487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
    Gemsenjäger E; Schweizer I
    Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma.
    Akslen LA; LiVolsi VA
    Cancer; 2000 Apr; 88(8):1902-8. PubMed ID: 10760768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytic infiltration in pediatric thyroid carcinomas.
    Van Savell H; Hughes SM; Bower C; Parham DM
    Pediatr Dev Pathol; 2004; 7(5):487-92. PubMed ID: 15547772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
    Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
    Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited.
    Kebebew E; Treseler PA; Ituarte PH; Clark OH
    World J Surg; 2001 May; 25(5):632-7. PubMed ID: 11369991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
    Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
    J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.